THE BEST SIDE OF PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS

“As API suppliers, we're a little bit in the middle,” Gomes suggests. “We see what is occurring with our consumers that are generic or branded drug manufacturers, but we also see what is happening within the earliest phase of the supply chain.In brief The COVID-19 pandemic didn't seriously impede the generation and shipment of pharmaceuticals